Overview

Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell

Status:
RECRUITING
Trial end date:
2027-08-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if a drug called Letermovir can help to prevent CMV reactivation.
Phase:
PHASE2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Treatments:
letermovir